A CBD oral formulation (named PTL 101) for the treatment of intractable epilepsy is being developed by MMJ PhytoTech Ltd (AU)
This unique mechanism has shown unprecedented results in early clinical trials, with participants losing over 24% of their body weight in less than a year at the highest studied doses Because of its potency, dosing strategy is at the center of how Retatrutide works
TripleHormoneReceptor Agonist Retatrutide for Obesity A Phase 2 Trial
Regular follow-ups, balanced eating, and consistent activity help preserve results, with some individuals continuing semaglutide as needed
Anyone purporting to sell retatrutide for human use is breaking the law, and no one should consider taking anything claiming to be retatrutide outside of a Lilly-sponsored clinical trial. More on weight loss drugs: Scientists Testing GLP-1s for Overweight Dogs and Cats
Retatrutide is not FDA approved and is not available by prescription